Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8857 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8857 |
High Similarity |
NPD1613 |
Approved |
0.8777 |
High Similarity |
NPD3027 |
Phase 3 |
0.8571 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.85 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.844 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8322 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8291 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8187 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8165 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8165 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8165 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.816 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8071 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8037 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8037 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8037 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7986 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7975 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7975 |
Intermediate Similarity |
NPD37 |
Approved |
0.7975 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7937 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7834 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7831 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7823 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7786 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7778 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.774 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7738 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7718 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7718 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7708 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7702 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7679 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7647 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7635 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7633 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7588 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7586 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7574 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7561 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7554 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.755 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7548 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7534 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7517 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7483 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7482 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7471 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7468 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7456 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7453 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7447 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7442 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7439 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7432 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7432 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7419 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7414 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7414 |
Intermediate Similarity |
NPD8054 |
Approved |
0.741 |
Intermediate Similarity |
NPD228 |
Approved |
0.7389 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7386 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7384 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7381 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7375 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7358 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7358 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7351 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7341 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7329 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7321 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.732 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7314 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7308 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7308 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7299 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.729 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7278 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7266 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7266 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7255 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7246 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7244 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7244 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7237 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7233 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7232 |
Intermediate Similarity |
NPD4663 |
Approved |
0.723 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7226 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7226 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7215 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7208 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7208 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7203 |
Intermediate Similarity |
NPD6671 |
Approved |
0.72 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7197 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7195 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7195 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7194 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7193 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7193 |
Intermediate Similarity |
NPD27 |
Approved |
0.7192 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7192 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7186 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7176 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7171 |
Intermediate Similarity |
NPD7095 |
Approved |
0.717 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7169 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7168 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7159 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7159 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7159 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7159 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7159 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7159 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7135 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7135 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7134 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7126 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7126 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7125 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7125 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7123 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7122 |
Intermediate Similarity |
NPD290 |
Approved |
0.7119 |
Intermediate Similarity |
NPD7309 |
Approved |
0.7118 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7114 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7107 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7107 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7099 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7089 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7078 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7076 |
Intermediate Similarity |
NPD6071 |
Discontinued |
0.707 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.707 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.707 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7069 |
Intermediate Similarity |
NPD8156 |
Discontinued |
0.7067 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7066 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7063 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD6353 |
Approved |
0.7051 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7048 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7045 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7044 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7035 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7032 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7032 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7032 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7024 |
Intermediate Similarity |
NPD5402 |
Approved |
0.702 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7011 |
Intermediate Similarity |
NPD8252 |
Approved |
0.7011 |
Intermediate Similarity |
NPD8099 |
Discontinued |
0.7011 |
Intermediate Similarity |
NPD8251 |
Approved |
0.7006 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD3060 |
Approved |
0.6994 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6981 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6981 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6981
|
Remote Similarity |
NPD1375 |
Discontinued |